3/31
01:39 pm
bcda
BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
Low
Report
BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
3/31
08:00 am
bcda
Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
High
Report
Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
3/26
04:30 pm
bcda
BioCardia Reports 2024 Business Highlights and Financial Results
Medium
Report
BioCardia Reports 2024 Business Highlights and Financial Results
3/21
08:30 am
bcda
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025
Medium
Report
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025
3/10
09:15 am
bcda
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
Low
Report
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
2/27
07:08 pm
bcda
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions [Yahoo! Finance]
Medium
Report
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions [Yahoo! Finance]
2/27
09:15 am
bcda
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
Low
Report
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
2/22
11:52 pm
bcda
Creditors continue to hound Santa Fe real estate magnate [Yahoo! Finance]
High
Report
Creditors continue to hound Santa Fe real estate magnate [Yahoo! Finance]
2/13
09:40 am
bcda
BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) [Yahoo! Finance]
Low
Report
BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) [Yahoo! Finance]
2/13
08:30 am
bcda
BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF)
Low
Report
BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF)
2/1
05:58 am
bcda
BioCardia, Inc. (NASDAQ: BCDA) was upgraded by analysts at Alliance Global Partners from a "hold" rating to a "strong-buy" rating.
Low
Report
BioCardia, Inc. (NASDAQ: BCDA) was upgraded by analysts at Alliance Global Partners from a "hold" rating to a "strong-buy" rating.
1/27
09:15 am
bcda
BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions
Medium
Report
BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions